IFP Advisors, Inc - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,436
+530.1%
1,340
+168.0%
0.00%
Q1 2023$1,815
+15025.0%
500
-75.3%
0.00%
Q4 2022$12
-99.9%
2,023
-15.7%
0.00%
Q3 2022$9,0000.0%2,3990.0%0.00%
Q2 2022$9,0000.0%2,3990.0%0.00%
Q1 2022$9,0002,3990.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$7,000
+133.3%
1,324
+32.4%
0.00%
Q3 2017$3,0000.0%1,0000.0%0.00%
Q2 2017$3,000
+50.0%
1,0000.0%0.00%
Q1 2017$2,000
+100.0%
1,0000.0%0.00%
Q4 2016$1,0000.0%1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,0001,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders